4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(2-ethyl-6-methylphenyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Chemical Structure Depiction of
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(2-ethyl-6-methylphenyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(2-ethyl-6-methylphenyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Compound characteristics
| Compound ID: | L309-1313 |
| Compound Name: | 4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(2-ethyl-6-methylphenyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide |
| Molecular Weight: | 482.56 |
| Molecular Formula: | C24 H26 N4 O5 S |
| Smiles: | CCc1cccc(C)c1NS(c1ccc2c(c1)N(Cc1nc(C3CCC3)on1)C(CO2)=O)(=O)=O |
| Stereo: | ACHIRAL |
| logP: | 3.5668 |
| logD: | 3.5642 |
| logSw: | -3.8038 |
| Hydrogen bond acceptors count: | 10 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 96.513 |
| InChI Key: | CHIXJIWPICDAAH-UHFFFAOYSA-N |